Providers are voicing concern over HHS Secretary Robert F. Kennedy Jr.’s firing of the vice chairs of the U.S. Preventive Services Task Force (USPSTF). They say the move raises fresh

After disrupting the prescription drug market with Cost Plus Drugs — which now has the White House seal of approval — Mark Cuban has quietly turned to the employer market. Since

Healthcare revenue cycle management (RCM) sits at an inflection point. Advances in AI are expanding what is possible across healthcare, with generative models expected to drive meaningful productivity gains.  That

Two large, international healthcare investment firms announced their plans to merge on Wednesday.  The partners — London-based GHO Capital and Singapore-based CBC Group — said the deal will combine $21

Both the Trump and Biden administrations made immense strides in improving healthcare interoperability —for instance, with information blocking penalties as part of the 21st Century Cures Act and the launch

A BioMarin Pharmaceutical deal last year brought the company a late-stage therapy that fit its extensive enzyme replacement experience while also offering the potential to become the first treatment for

Nourish, a metabolic health clinic, announced Tuesday that it raised $100 million in Series C funding, which will help grow its clinical network. New York City-based Nourish has more than

Many conversations about the U.S. healthcare workforce start with the same word: shortage. Legislators want to fund more residency slots. Medical schools are expanding enrollment. Policy papers project the deficit

John Ayers believes most healthcare AI hype has not yet translated into meaningful patient impact — though he thinks that may soon change. This belief drove Ayers and a team

In a recent letter, a group of 48 employer and consumer organizations are calling on the Trump Administration to strengthen oversight of certified independent dispute resolution (IDR) entities, which resolve